査読有
doi:10.1016/j.jhep.2023.12.004
PubMed No.:38110007
2022 Impact Factor:25.7
種類:Letter to the Editor
誌名:Journal of Hepatology
発行年月:2023年12月
巻号頁:in press
論題:Changing from NAFLD to MASLD: Similar Prognosis of Unresectable Extrahepatic Gastrointestinal Cancer Under Chemotherapy between NAFLD and MASLD
著者:Hiroyuki Suzuki, Toshimitsu Tanaka, Shotaro Yamaguchi, Keisuke Miwa, Takumi Kawaguchi